The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
G

De-Escalation of HPV-Mediated (p16+) Oropharynx Cancer Treatment: Rationale for Altered and Radiotherapy, and Surgery Followed by Radiation De-Escalation

By 2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium FEATURING Gregory Gan
By 2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium FEATURING Gregory Gan
23 views
November 12, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
2019 Lung Cancer and Head & Neck Cancer Symposium
08:12

Understanding the Distinction of HPV-Mediated (p16+) Oropharynx Canc…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

G. Gan

92 views
12:23

De-Escalation of HPV-Mediated (p16+) Oropharynx Cancer Treatment: Ra…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

G. Gan

23 views
10:27

De-Escalation of HPV-Mediated (p16+) Oropharynx Cancer Treatment: TO…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

G. Gan

207 views
19:34

Evaluation and Managing Options of the Adult Neck Mass in the Era of…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

A. Bur

275 views
06:51

2019 Update on the HPV+ Oropharynx Carcinoma: Cisplatin and Concurre…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

P. Neupane

41 views
06:20

2019 Update on Locally Advanced Nasopharyngeal Cancer: Induction Che…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

P. Neupane

46 views
08:21

2019 Update on Recurrent/Metastatic Head&Neck Squamous Cell Carcinom…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

P. Neupane

569 views
12:55

2019 Update on Salivary Gland Carcinoma: Anti-HER2 w/o or w/Chemo Do…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

P. Neupane

39 views
17:19

The Use of IO Agents in Metastatic NSCLC: Overview of Anti-PD-1/Anti…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

D. Gibbons

846 views
10:16

Immunotherapy in Advanced NSCLC: Difficulties With Biomarkers Develo…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

D. Gibbons

89 views
13:33

Checkpoint Inhibitors in Stage III NSCLC (Pacific Trial Regimen) / B…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

D. Gibbons

129 views
17:11

Microbiome as a Predictive Ecosystem for Immunotherapy in NSCLC Can …

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

J. Zhang

38 views
12:42

New KRAS G12C / MET Exon 14 TKI’s for Advanced NSCLC: Favorable Safe…

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

C. Huang

430 views
22:41

New TKI’s in Development for Lung Cancer. An Overview of New ROS1 / …

2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium

C. Huang

338 views